Ginsenoside Rg1 improves anti-tumor efficacy of adoptive cell therapy by enhancing T cell effector functions

Adoptive cell therapy (ACT) has emerged with remarkable efficacies for tumor immunotherapy. Chimeric antigen receptor (CAR) T cell therapy, as one of most promising ACTs, has achieved prominent effects in treating malignant hematological tumors. However, the insufficient killing activity and limited...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yue, An, Lingna, Yang, Chengfei, Wang, Xiaoqi, Huang, Ruihao, Zhang, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400057/
https://www.ncbi.nlm.nih.gov/pubmed/37546705
http://dx.doi.org/10.1097/BS9.0000000000000165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400057/
https://www.ncbi.nlm.nih.gov/pubmed/37546705
http://dx.doi.org/10.1097/BS9.0000000000000165

Ejemplares similares